Success rate
Clinical trial success across retinal and bionic devices%
Early trials achieved transition success as high as 84.8% in Phase I, while specific functional tasks dropped to just 5% when devices were turned off.
The numbers
| 1 | Phase I Transition Success Rate (BIO 2006-2015) | 84.8 |
| 2 | Retinal Prosthesis Simulation Irregularity-Optimized Character Recognition Rate | 80 |
| 3 | Phase I Transition Success Rate (Wong et al. 2000-2015) | 73.7 |
| 4 | Phase I Transition Success Rate (BIO 2011-2020) | 71.6 |
| 5 | Phase II Transition Success Rate (Wong et al. 2000-2015) | 71.4 |
| 6 | Argus II Retinal Prosthesis Line Task Success (Device ON, 5-Year Follow-up) | 70 |
| 7 | Argus II Clinical Study Line Task Success Rate (Device ON - AHRQ Review) | 68 |
| 8 | Epiretinal Prosthesis Door Localization Task Success (Device ON - NICE Overview) | 60 |
| 9 | Argus II Clinical Study Door Task Success Rate (Device ON - AHRQ Review) | 54 |
| 10 | Argus II Retinal Prosthesis Door Task Success (Device ON, 5-Year Follow-up) | 50 |
| 11 | 60-Electrode Retinal Prosthesis Sock Classification Task Success Rate | 50 |
| 12 | Phase III Transition Success Rate (Thomas et al. / Ophthalmology Benchmark) | 47 |
| 13 | Phase II Transition Success Rate (Thomas et al. / Ophthalmology Benchmark) | 36 |
| 14 | Argus II Clinical Study Door Task Success Rate (Device OFF - AHRQ Review) | 27 |
| 15 | Argus II Clinical Study Line Task Success Rate (Device OFF - AHRQ Review) | 23 |
| 16 | Argus II Retinal Prosthesis Door Task Success (Device OFF, 5-Year Follow-up) | 20 |
| 17 | Argus II Retinal Prosthesis Line Task Success (Device OFF, 5-Year Follow-up) | 20 |
| 18 | Epiretinal Prosthesis Door Localization Task Success (Device OFF - NICE Overview) | 5 |